Title : CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials.

Pub. Date : 2020 Sep

PMID : 33004739






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Many randomized controlled trials (RCTs) showed promising results that men with metastatic castration-resistant PCa (mCRPC) might benefit from treatment with CYP17 inhibitors such as abiraterone acetate and orteronel. orteronel cytochrome P450 family 17 subfamily A member 1 Homo sapiens